Spinal Concepts' InFix
This article was originally published in The Gray Sheet
Clinical trials of the interbody fusion system for lumbar spine fusion procedures begin immediately following investigational device exemption approval, the firm reports May 21. Compared to competing systems, "the InFix interbody fusion cage does not violate endplate integrity and accounts for differing disk width, height, and lordosis, or bed of the spine," Stephen Hochschuler, Texas Back Institute, claims in the company's release. Spinal Concepts highlights the system's modular design, which provides "numerous options" for matching lordosis, plate size and disc height. One device is needed to complete a procedure versus two necessary in most fusion surgeries, the firm notes
You may also be interested in...
Asking whether FDA’s decision to allow emergency use of two old anti-malarial drugs was ‘political’ misses the point. The issue already was political, and FDA’s action may well be the best way to keep some measure of federal control on supplies of a drug with important other uses.
Guidelines for health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.